APA (7th ed.) Citation

R, G., R, C., C, B., ML, S., M, B., B, G., . . . O, M. (2024). MetSCORE: A molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics. Cardiovascular diabetology, 23(1), 272. https://doi.org/10.1186/s12933-024-02363-3

Chicago Style (17th ed.) Citation

R, Gil-Redondo, et al. "MetSCORE: A Molecular Metric to Evaluate the Risk of Metabolic Syndrome Based on Serum NMR Metabolomics." Cardiovascular Diabetology 23, no. 1 (2024): 272. https://doi.org/10.1186/s12933-024-02363-3.

MLA (9th ed.) Citation

R, Gil-Redondo, et al. "MetSCORE: A Molecular Metric to Evaluate the Risk of Metabolic Syndrome Based on Serum NMR Metabolomics." Cardiovascular Diabetology, vol. 23, no. 1, 2024, p. 272, https://doi.org/10.1186/s12933-024-02363-3.